CD274 and neoplasm: After combination with the PD-L1 antibody, the primary tumor was almost completely depleted, and the growth of distant tumor was also considerably inhibited, suggesting that the combination with checkpoint blockade immunotherapy could improve the antitumor effect both at primary and distant tumors.